Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Peerlinck

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Seminars in Hematology|January 24, 2006
Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitorsRoseline d'Oiron, F Volot, J Reynaud, et al.
Thrombosis and Haemostasis|October 6, 1998
The molecular basis of antithrombin deficiency in Belgian and Dutch familiesK Jochmans, W Lissens, S Seneca, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control studyA S van Velzen, C L Eckhardt, M Peters, et al.
Blood|July 27, 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factorM Jacquemin, R Lavend'homme, A Benhida, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2013
Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parametersA Tuinenburg, S Biere-Rafi, M Peters, et al.
Blood|July 13, 2000
Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemiaM Neerman-Arbez, P de Moerloose, C Bridel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Factor VIII deficiency does not protect against atherosclerosisSara Biere-Rafi, A Tuinenburg, B W Haak, et al.
Journal of Thrombosis and Haemostasis : JTH|February 11, 2012
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding DisordersF Peyvandi, R Palla, M Menegatti, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Seminars in Hematology|January 24, 2006
Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitorsRoseline d'Oiron, F Volot, J Reynaud, et al.
Thrombosis and Haemostasis|October 6, 1998
The molecular basis of antithrombin deficiency in Belgian and Dutch familiesK Jochmans, W Lissens, S Seneca, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control studyA S van Velzen, C L Eckhardt, M Peters, et al.
Blood|July 27, 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factorM Jacquemin, R Lavend'homme, A Benhida, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2013
Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parametersA Tuinenburg, S Biere-Rafi, M Peters, et al.
Blood|July 13, 2000
Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemiaM Neerman-Arbez, P de Moerloose, C Bridel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Factor VIII deficiency does not protect against atherosclerosisSara Biere-Rafi, A Tuinenburg, B W Haak, et al.
Journal of Thrombosis and Haemostasis : JTH|February 11, 2012
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding DisordersF Peyvandi, R Palla, M Menegatti, et al.
Pageof 9